Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 May;116(5):e2348.
doi: 10.1002/bdr2.2348.

Absent or hypoplastic nasal bone: What to tell the prospective parents?

Affiliations
Observational Study

Absent or hypoplastic nasal bone: What to tell the prospective parents?

Shreya Das et al. Birth Defects Res. 2024 May.

Abstract

Background: Absent or hypoplastic nasal bone (AHNB) on first or second-trimester ultrasonography (USG) is an important soft marker of Down syndrome. However, due to its varied incidence in euploid and aneuploid fetuses, there is always a dilemma of whether to go for invasive fetal testing for isolated AHNB. This study aims to assess outcomes specifically within the context of Indian ethnicity women.

Materials and methods: This was a prospective observational study. All patients who reported with AHNB in the first- or second-trimester USG were included. Genetic counseling was done, and noninvasive and invasive testing was offered. Chromosomal anomalies were meticulously recorded, and pregnancy was monitored.

Results: The incidence of AHNB in our study was 1.16% (47/4051). Out of 47 women with AHNB, the isolated condition was seen in 32 (0.78%) cases, while AHNB with structural anomalies was seen in nine cases (0.22%). Thirty-nine women opted for invasive testing. Six out of 47 had aneuploidy (12.7%), while two euploid cases (4.25%) developed nonimmune hydrops. The prevalence of Down syndrome in fetuses with AHNB was 8.5% (4/47) and 0.42% (17/4004) in fetuses with nasal bone present. This difference was statistically significant (p = .001).

Conclusion: The results indicate that isolated AHNB cases should be followed by a comprehensive anomaly scan rather than immediately recommending invasive testing. However, invasive testing is required when AHNB is associated with other soft markers or abnormalities. As chromosomal microarray is more sensitive than standard karyotype in detecting chromosomal aberrations, it should be chosen over karyotype.

Keywords: Down syndrome (DS); absent or hypoplastic nasal bone; amniocentesis; aneuploidy; karyotype; microarray; soft markers.

PubMed Disclaimer

References

REFERENCES

    1. Agathokleous, M., Chaveeva, P., Poon, L. C. Y., Kosinski, P., & Nicolaides, K. H. (2013). Meta‐analysis of second‐trimester markers for trisomy 21. Ultrasound in Obstetrics & Gynecology, 41(3), 247–261. https://doi.org/10.1002/uog.12364
    1. Akalın, M., Demirci, O., Dizdaroğulları, G. E., Çiftçi, E., & Karaman, A. (2023). Contribution of chromosomal microarray analysis and next‐generation sequencing to genetic diagnosis in fetuses with normal karyotype. The Journal of Obstetrics and Gynaecology Research, 49(2), 519–529. https://doi.org/10.1111/jog.15486
    1. Alfirevic, Z., Navaratnam, K., & Mujezinovic, F. (2017). Amniocentesis and chorionic villus sampling for prenatal diagnosis. The Cochrane Database of Systematic Reviews, 9(9), CD003252. https://doi.org/10.1002/14651858.CD003252.pub2
    1. Bansal, V., & Jhaveri, R. (2022). Prenatal invasive testing at a tertiary referral Center in India: A report of 433 cases under a single operator. Journal of Obstetrics and Gynaecology of India, 72(1), 47–58. https://doi.org/10.1007/s13224-021-01496-9
    1. Benacerraf, B. R., Bromley, B., & Jelin, A. C. (2019). Absent nasal bone. American Journal of Obstetrics and Gynecology, 221(5), B6–B7. https://doi.org/10.1016/j.ajog.2019.08.049

Publication types

LinkOut - more resources